The Drug Controller General of India (DCGI) has urged Pfizer, Johnson and Johnson multiple time in writing to apply for emergency use authorisation for their Covid-19 vaccine so that application is processed well in time but the pharma companies have not applied for the license yet.

According to media reports, drug regulators are talking to them, but they say we are working on it. Another pharma conglomorate Moderna is supposed to donate seven million doses to India from the United States under Covax, which is still pending. As DCGI approved Moderna, Cipla will import the vaccines from the US but there has been no decision on legal indemnity so far. Recently, Dr. V K Paul, Member, Niti Aayog, said, "Talks initiatives, no reply has come from them. We are waiting for the process. Negotiations are on with a positive mind."

Moderna and Pfizer had sought indemnity which would ensure that they can't be booked in case of any adverse effect of the vaccine. 

Covid Impact on Students Health: 85 pc of children report ‘learning loss’

Johnson & Johnson Covid vaccine raises risk of rare neurological disorder: FDA

Experts suggests, Covid-affected people to keep kidney health in check